Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin in Pig against Korean Local Isolates of Actinobacillus pleuropneumoniae

Table 4

The pharmacodynamic parameters of marbofloxacin against 20 isolates of Actinobacillus pleuropneumonia.

Strain number	Concentration range (μg/mL)	MIC (μg/mL)	MBC (μg/mL)	MBC/MIC
1	32–0.00391	0.0625	0.0625	1
2	32–0.00391	0.0625	0.25	4
3	32–0.00391	0.125	0.125	1
4	32–0.00391	0.125	0.125	1
5	32–0.00391	0.0625	0.5	8
6	32–0.00391	0.125	0.25	2
7	32–0.00391	0.125	1	8
8	32–0.00391	0.125	0.25	2
9	32–0.00391	0.125	0.25	2
10	32–0.00391	0.0625	0.0625	1
11	32–0.00391	0.5	2	4
12	32–0.00391	0.5	2	4
13	32–0.00391	0.0625	0.25	4
14	32–0.00391	0.125	0.125	1
15	32–0.00391	0.25	2	8
16	32–0.00391	0.125	0.25	2
17	32–0.00391	0.0313	0.0625	2
18	32–0.00391	0.0625	0.0625	1
19	32–0.00391	1	8	8
20	32–0.00391	0.25	4	16